TABLE 2.
Distribution of ESBL producers among the participant centers
| ESBL type | No. of ESBL-producing isolatesa from center no.:
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 (n = 122) | 2 (n = 282) | 3 (n = 245) | 4 (n = 119) | 5 (n = 110) | 6 (n = 178) | 7 (n = 125) | 8 (n = 158) | 9 (n = 107) | 10 (n = 155) | 11 (n = 283) | 12 (n = 236) | 13 (n = 268) | |
| CTX-M | 6 | 25 | 21 | 5 | 10 | 20 | 6 | 10 | 5 | 5 | 70 | 34 | 2 |
| SHV | 2 | 1 | 6 | 2 | 4 | 3 | 2 | 2 | 25 | ||||
| TEM | 1 | 1 | |||||||||||
| Total no. (%) | 8 (6.6) | 26 (9.2) | 27 (11.0) | 5b (4.2) | 13b (11.8) | 20 (11.2) | 6 (4.8) | 12b (7.6) | 7 (6.5) | 8 (5.2) | 96 (33.9) | 34 (14.4) | 2 (0.7) |
a
The total number of isolates from each center is indicated in parentheses.
b
Two isolates from center 4, one isolate from center 5, and one isolate from center 8 with two ESBLs (CTX-M and SHV types) were identified.